News

A recent discovery has lead to promising potential treatments for pancreatic cancer.

Researchers have designed DNA-based nanogels that only break down and release their chemotherapeutic contents within cancer cells, potentially eliminating painful and uncomfortable side effects.

Researchers at Tel Aviv University (TAU) have demonstrated that the CRISPR/Cas9 system is very effective in treating metastatic cancers, a significant step on the way to finding a cure for cancer. The researchers developed a novel lipid nanoparticle-based delivery system that specifically targets cancer cells and destroys them by genetic manipulation.

A simple and inexpensive blood test could pick out patients with stomach or oesophageal cancer who are likely to benefit from targeted treatment, a new study shows.

A research team focused on treating cancer metastasis by delivering immune-cell-attracting chemicals into lung cancers via red blood cells.

The new predictive tool has been developed by using an advanced microscopy platform that identifies the interactions between the immune cells and the tumor cells and also provides information about the activation state of the immune checkpoints that buffer the anti-tumor response.

Researchers from Duke-NUS Medical School, Erasmus University Medical Center, Yale-NUS College and Duke University have found a potential way to predict who will respond to cancer therapies that block Wnt production.

Scientists at Duke-NUS Medical School have found a way to systematically investigate their functions and discovered some could play a role in pancreatic cancer.

Sometimes cells survive after what was considered the critical step in cellular suicide. Now, scientists have identified two key factors involved in this recovery.

Light-activated liposomes could help to deliver CRISPR gene therapy – and the method could prove safer and more direct than current methods.